Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Thus, Rsk2 loss-of-function, as seen in CLS, perturbs the differentiation of neural precursors into neurons, and maintains them instead as proliferating radial precursor cells, a defect that may underlie the cognitive dysfunction seen in CLS.
|
20832397 |
2010 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
The first large duplication of the RSK2 gene identified in a Coffin-Lowry syndrome patient.
|
17717706 |
2007 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
Gene deletion studies in mice have shown an essential role for the Rsk2 gene in osteoblast differentiation and function, establishing a causal link between Rsk2 deficiency and skeletal abnormalities of CLS.
|
17033934 |
2007 |
Coffin-Lowry syndrome
|
1.000 |
AlteredExpression
|
disease |
BEFREE |
Reconstitution of RSK2 in cells from subjects with a genetic defect in RSK2 expression (Coffin-Lowry syndrome) enhanced Tat transactivation.
|
17225856 |
2007 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
Cerebellum and hippocampus volumes were particularly impacted by CLS and may be associated with specific interfamilial RSK2 mutations.
|
17318637 |
2007 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Cerebellum and hippocampus volumes were particularly impacted by CLS and may be associated with specific interfamilial RSK2 mutations.
|
17318637 |
2007 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Here we present 44 novel mutations in RSK2 causing CLS.
|
16879200 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
A novel RSK2 (RPS6KA3) gene mutation associated with abnormal brain MRI findings in a family with Coffin-Lowry syndrome.
|
16691578 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Here we present 44 novel mutations in RSK2 causing CLS.
|
16879200 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
A novel RSK2 (RPS6KA3) gene mutation associated with abnormal brain MRI findings in a family with Coffin-Lowry syndrome.
|
16691578 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation.
|
17100996 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Because RSK2-inactivating mutations in humans lead to Coffin-Lowry syndrome, our results imply that alterations in GPCR signaling may account for some of its clinical manifestations.
|
16537434 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Mutations in the RSK2(RPS6KA3) gene cause Coffin-Lowry syndrome and nonsyndromic X-linked mental retardation.
|
17100996 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
LHGDN |
Here we present 44 novel mutations in RSK2 causing CLS.
|
16879200 |
2006 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
BEFREE |
Inactivation of the growth factor-regulated S6 kinase RSK2 causes Coffin-Lowry syndrome in humans, an X-linked mental retardation condition associated with progressive skeletal abnormalities.
|
15719069 |
2005 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
RSK2 gene mutations in Coffin-Lowry syndrome with drop episodes.
|
15668050 |
2005 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Delineation of the mechanisms of aberrant splicing caused by two unusual intronic mutations in the RSK2 gene involved in Coffin-Lowry syndrome.
|
14973203 |
2004 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Cardiomyopathy in Coffin-Lowry syndrome.
|
15214012 |
2004 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
These findings identify ATF4 as a critical regulator of osteoblast differentiation and function, and indicate that lack of ATF4 phosphorylation by RSK2 may contribute to the skeletal phenotype of CLS.
|
15109498 |
2004 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
CLINGEN |
The 90 kDa ribosomal S6 serine/threonine kinase 2 gene (RSK2, U08316) has been recently identified as a disease-causing gene in an X-linked disorder, the Coffin-Lowry Syndrome (MIM 303600) characterized by severe mental retardation, facial dysmorphisms and progressive skeletal malformations.
|
14678837 |
2004 |
Coffin-Lowry syndrome
|
1.000 |
AlteredExpression
|
disease |
LHGDN |
The 90 kDa ribosomal S6 serine/threonine kinase 2 gene (RSK2, U08316) has been recently identified as a disease-causing gene in an X-linked disorder, the Coffin-Lowry Syndrome (MIM 303600) characterized by severe mental retardation, facial dysmorphisms and progressive skeletal malformations.
|
14678837 |
2004 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
UNIPROT |
Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome.
|
14986828 |
2003 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
Intronic L1 insertion and F268S, novel mutations in RPS6KA3 (RSK2) causing Coffin-Lowry syndrome.
|
14986828 |
2003 |
Coffin-Lowry syndrome
|
1.000 |
Biomarker
|
disease |
MGD |
Insulin resistance and lipodystrophy in mice lacking ribosomal S6 kinase 2.
|
12765942 |
2003 |
Coffin-Lowry syndrome
|
1.000 |
GeneticVariation
|
disease |
BEFREE |
CLS is caused by mutations in a gene located in Xp22.2 and encoding RSK2, a growth-factor regulated protein kinase.
|
11896450 |
2002 |